John L. Green

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John L. Green:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Financial Officer Common Stock 131,834 $5,099,339 $38.68 26 Dec 2025 Direct
Cogent Biosciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 65,000 $1,940,058 $7.19 17 Dec 2025 Direct

Insider Reports Filed by John L. Green

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COGT Cogent Biosciences, Inc. 26 Dec 2025 1 -$2,978,360 4 Chief Financial Officer 30 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 17 Dec 2025 4 -$5,720,526 4 Chief Financial Officer 19 Dec 2025, 16:01
COGT Cogent Biosciences, Inc. 23 Jan 2025 1 $0 4 Chief Financial Officer 27 Jan 2025, 17:03
COGT Cogent Biosciences, Inc. 23 Jan 2024 1 $0 4 Chief Financial Officer 25 Jan 2024, 16:17
COGT Cogent Biosciences, Inc. 13 Feb 2023 1 $0 4 Chief Financial Officer 15 Feb 2023, 14:50
COGT Cogent Biosciences, Inc. 25 Jan 2022 1 +$1,112,220 4 Chief Financial Officer 27 Jan 2022, 16:47